Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03778372 · ClinicalTrials.gov registry record
Methadone for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
A clinical trial, sponsored by Ochsner Health System.
- Completed
- Registry status
- 55
- Enrollment target
NCT03778372: Completed study, sponsored by Ochsner Health System.
NCT03778372 is a clinical trial that has completed, run by Ochsner Health System. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03778372 has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
Strabismus surgery for children is a very common procedure, with a high incidence of emergence delirium in the recovery room. Pain is often implicated in delirium. The primary aim of this study is to determine whether a single, intraoperative dose of methadone for outpatient ambulatory pediatric strabismus surgery reduces postoperative delirium.
Primary Outcome
A low total score would indicate less emergence delirium
Interventions
- DRUG Methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-12-13 |
What the finished NCT03778372 record still lists
NCT03778372 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Methadone is the first listed.
NCT03778372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03778372 about?
NCT03778372 is a clinical study titled "Methadone for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery". Strabismus surgery for children is a very common procedure, with a high incidence of emergence delirium in the recovery room. Pain is often implicated in delirium. The primary aim of this study is to determine whether a single, intraoperative dose of methadone for outpatient ambulatory pediatric str...
What is the current status of trial NCT03778372?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2019-01-01. Estimated completion is 2020-12-13.
What interventions are being tested in trial NCT03778372?
The interventions under investigation include: Methadone (DRUG).
Who is sponsoring clinical trial NCT03778372?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI